The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition

Sponsor: The University of Texas Health Science Center at San Antonio
Collaborators: University of Texas, South Texas Veterans Health Care System

Purpose

Determine the effects of Niagen (nicotinamide riboside, vitamin B3), on NAD levels, brain function including cognition and blood flow in people diagnosed with mild cognitive impairment (MCI).

Study Design

Double blind, factorial

Dose

Escalating dose from 250mg/day to 1000mg/day

Length of Intervention

10 weeks

Intrinsic Capacity

Cognition

Status

Lorem ipsum

Condition or Disease 

Mild Cognitive Impairment
NAD

Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.

Clinical Studies, Cognition, Active - Not RecruitingANAD Staff